Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant

Blood Advances · Published 2026-07-17 · DOI 10.1182/bloodadvances.2025018166

Free full text

Authors (12)

Elisabetta Xue, Sanchita Das, Hyoyoung Choo-Wosoba, Dimana Dimitrova, Mustafa A. Hyder, Francis A. Flomerfelt, Brian Dawson, William Telford, Kalpana Dulal Upadhyaya, Kamil Rechache, Christopher G. Kanakry, Jennifer A Kanakry

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xue, E., Das, S., Choo-Wosoba, H., et al. (2026). Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant. Blood Advances. https://doi.org/10.1182/bloodadvances.2025018166

Related articles

• Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry · Blood Advances · 2026 · Same journal
• Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development · Blood Advances · 2026 · Same journal
• Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia · Blood Advances · 2026 · Same journal
• Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q · Blood Advances · 2026 · Same journal
• Reframing Hematologic and Thrombovascular Care for Transgender and Gender-Diverse Individuals: A Scoping Review · Blood Advances · 2026 · Same journal
• Optimizing outcomes and accessibility of matched sibling donor transplant for transfusion dependent thalassemia in LMICs · Blood Advances · 2026 · Same journal
• The zebrafish model tackles anti-P2Y12 variability in humans: a translational approach · Blood Advances · 2026 · Same journal
• A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia · Blood Advances · 2026 · Same journal
• In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway · Blood Advances · 2026 · Same journal
• JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation · Blood Advances · 2026 · Same journal